EQUEST EQUINE GEL
Country: United Kingdom
Language: English
Source: HMA (Heads of Medicines Agencies)
Summary of Product characteristics
(SPC)
19-04-2013
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
moxidectin 18.92 mg
Available from:
Pfizer Animal Health
ATC code:
QP54AB02
Pharmaceutical form:
Oral gel
Therapeutic group:
moxidectin
Therapeutic area:
Horses
Authorization date:
2012-02-21
Summary of Product characteristics
1
SUMMARY OF PRODUCT CHARACTERISTICS
2
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
EQUEST ORAL GEL, 18,92 mg/g, oral gel for horses and ponies
(Sweden: Cydectin Vet)
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Qualitative composition
Quantitative composition
Each g contains:
ACTIVE SUBSTANCE:
Moxidectin
18.92 mg
EXCIPIENTS QSP:
Benzyl Alcohol (E1519)
Disodium Edetate
37.84 mg
0.24 mg
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Oral Gel.
Yellow Gel.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Horses and ponies.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
The veterinary medicinal product is indicated for treatment of infections caused by moxidectin
sensitive strains of:
Large strongyles:
_Strongylus vulgaris_ (adults and arterial stages)
_Strongylus edentatus_ (adults and visceral stages)
_Triodontophorus brevicauda_ (adults)
_Triodontophorus serratus_ (adults)
_Triodontophorus tenuicollis _ (adults)
Small strongyles (adults and intraluminal larval stages):
_Cyathostomum _spp.
_Cylicocyclus _spp_._
_Cylicostephanus _spp_._
_Cylicodontophorus_ spp.
_Gyalocephalus _spp.
Ascarids:
_Parascaris equorum_ (adult and larval stages)
3
Other species:
_Oxyuris equi _(adult and larval stages)
_Habronema muscae _(adults)_ _
_Gasterophilus intestinalis _(L2, L3)
_Gasterophilus nasalis _(L2, L3)
_Strongyloides westeri _(adults)
_Trichostrongylus axei_
The veterinary medicinal product has a persistent efficacy
Read the complete document
